IL-17A binding agent and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9862765
APP PUB NO 20160289321A1
SERIAL NO

15035550

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided is an antibody capable of specially recognizing IL-17A and binding to IL-17A. The antibody can be used for treating inflammation and autoimmune diseases caused by elevated expression of interleukin-17A, such as psoriasis, psoriatic arthritis, ankylosing spondylitis, multiple sclerosis, and inflammatory arthritis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SHANGHAI HENGRUI PHARMACEUTICAL CO LTDNO 279 WENJING ROAD MINHANG DISTRICT SHANGHAI 200245
JIANGSU HENGRUI MEDICINE CO LTD222047 NO 7 KUNLUN MOUNTAIN ROAD LIANYUNGANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE JIANGSU LIANYUNGANG CITY JIANGSU PROVINCE 222047

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cao, Guoqing Shanghai, CN 36 159
Liu, Jiajian Shanghai, CN 21 255
Sun, Piaoyang Jiangsu, CN 52 122
Zhang, Lianshan Shanghai, CN 78 687

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 9, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 9, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00